Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids - PubMed (original) (raw)

Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids

H P Hammes et al. Diabetologia. 1996 Mar.

Abstract

Omega-3 fatty acids exert several important biological effects on factors that may predispose to diabetic retinopathy. Potential pathogenetic mechanisms include platelet dysfunction, altered eicosanoid production, increased blood viscosity in association with impaired cell deformability and pathologic leucocyte/endothelium interaction. Therefore, we tested whether a 6-month administration of fish oil (750 mg Maxepa, 5 times per week), containing 14% eicosapentaenoic acid (EPA) and 10% docosahexaenic acid, could inhibit the development of experimental retinopathy of the streptozotocin-diabetic rat. The efficiency of fish oil supplementation was evaluated by measuring EPA concentrations in total, plasma and membrane fatty acids and by measuring the generation of lipid mediators (leukotrienes and thromboxanes). Retinal digest preparations were quantitatively analysed for pericyte loss, and the formation of acellular capillaries. Omega-3 fatty acid administration to diabetic rats resulted in a twofold increase of EPA 20:5 in total fatty acids, and a reduction of the thromboxane ratio from 600 (untreated diabetic rats) to 50 (treated diabetic rats). Despite these biochemical changes, diabetes-associated pericyte loss remained unaffected and the formation of acellular, occluded capillaries was increased by 75% in the fish oil treated diabetic group (115.1 +/- 26.8; untreated diabetic 65.2 +/- 15.0 acellular capillary segments/mm2 of retinal area). We conclude from this study that dietary fish oil supplementation may be harmful for the diabetic microvasculature in the retina.

PubMed Disclaimer

Similar articles

• Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.
  Hammes HP, Bartmann A, Engel L, Wülfroth P. Hammes HP, et al. Diabetologia. 1997 Jun;40(6):629-34. doi: 10.1007/s001250050726. Diabetologia. 1997. PMID: 9222640
• Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
  Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Hammes HP, et al. Diabetologia. 1994 Jan;37(1):32-5. doi: 10.1007/BF00428774. Diabetologia. 1994. PMID: 8150227
• Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
  Krämer HJ, Stevens J, Grimminger F, Seeger W. Krämer HJ, et al. Biochem Pharmacol. 1996 Oct 25;52(8):1211-7. doi: 10.1016/0006-2952(96)00473-x. Biochem Pharmacol. 1996. PMID: 8937428
• Omega-3 fatty acids in prevention of diabetic retinopathy.
  Behl T, Kotwani A. Behl T, et al. J Pharm Pharmacol. 2017 Aug;69(8):946-954. doi: 10.1111/jphp.12744. Epub 2017 May 8. J Pharm Pharmacol. 2017. PMID: 28481011 Review.
• Marine lipids: overview "news insights and lipid composition of Lyprinol".
  Sinclair AJ, Murphy KJ, Li D. Sinclair AJ, et al. Allerg Immunol (Paris). 2000 Sep;32(7):261-71. Allerg Immunol (Paris). 2000. PMID: 11094639 Review.

Cited by

• Pathophysiology of diabetic retinopathy.
  Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Tarr JM, et al. ISRN Ophthalmol. 2013 Jan 15;2013:343560. doi: 10.1155/2013/343560. eCollection 2013. ISRN Ophthalmol. 2013. PMID: 24563789 Free PMC article. Review.
• Protective effect of Soluble Epoxide Hydrolase Inhibition in Retinal Vasculopathy associated with Polycystic Kidney Disease.
  Lin J, Hu J, Schlotterer A, Wang J, Kolibabka M, Awwad K, Dietrich N, Breitschopf K, Wohlfart P, Kannt A, Lorenz K, Feng Y, Popp R, Hoffmann S, Fleming I, Hammes HP. Lin J, et al. Theranostics. 2020 Jun 22;10(17):7857-7871. doi: 10.7150/thno.43154. eCollection 2020. Theranostics. 2020. PMID: 32685025 Free PMC article.
• Role of lipid-lowering agents in the management of diabetic retinopathy.
  Ioannidou E, Tseriotis VS, Tziomalos K. Ioannidou E, et al. World J Diabetes. 2017 Jan 15;8(1):1-6. doi: 10.4239/wjd.v8.i1.1. World J Diabetes. 2017. PMID: 28138358 Free PMC article.
• Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.
  Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouché A, Yuce A, Fujisawa H, Hermans B, Shani M, Jansen S, Hicklin D, Anderson DJ, Gardiner T, Hammes HP, Moons L, Dewerchin M, Collen D, Carmeliet P, D'Amore PA. Stalmans I, et al. J Clin Invest. 2002 Feb;109(3):327-36. doi: 10.1172/JCI14362. J Clin Invest. 2002. PMID: 11827992 Free PMC article.
• Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms.
  Dongare S, Gupta SK, Mathur R, Saxena R, Mathur S, Agarwal R, Nag TC, Srivastava S, Kumar P. Dongare S, et al. Mol Vis. 2016 Jun 9;22:599-609. eCollection 2016. Mol Vis. 2016. PMID: 27293376 Free PMC article.

References

1. 1. Arch Ophthalmol. 1960 Dec;64:904-11 - PubMed
2. 1. Lipids. 1989 Apr;24(4):299-304 - PubMed
3. 1. Exp Eye Res. 1980 Apr;30(4):401-10 - PubMed
4. 1. Diabetologia. 1976 Aug;12(4):367-74 - PubMed
5. 1. Annu Rev Pharmacol Toxicol. 1985;25:691-714 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program